Recombinant Mouse ANTXR2 Protein, N-His

Introduction to Recombinant Mouse ANTXR2 Protein

Recombinant Mouse ANTXR2 Protein, also known as Anthrax Toxin Receptor 2, is a type I transmembrane protein that plays a critical role in the pathogenesis of anthrax infection. It is a member of the Anthrax Toxin Receptor (ANTXR) family, which also includes ANTXR1 and ANTXR3. Recombinant Mouse ANTXR2 Protein is produced through genetic engineering techniques, making it a highly pure and specific protein with a wide range of applications in the field of biotechnology and research.

Structure of Recombinant Mouse ANTXR2 Protein

Recombinant Mouse ANTXR2 Protein is composed of 533 amino acids and has a molecular weight of approximately 59.6 kDa. It consists of an extracellular domain, a transmembrane domain, and a cytoplasmic domain. The extracellular domain contains a von Willebrand factor A (VWA) domain, a furin-like cysteine-rich region, and an immunoglobulin (Ig)-like domain. The transmembrane domain anchors the protein to the cell membrane, while the cytoplasmic domain contains a conserved NPXY motif, which is essential for intracellular signaling.

Activity of Recombinant Mouse ANTXR2 Protein

Recombinant Mouse ANTXR2 Protein is a high-affinity receptor for anthrax toxin, a virulence factor produced by the bacterium Bacillus anthracis. The VWA domain of ANTXR2 binds to the protective antigen (PA) component of anthrax toxin, allowing the toxin to enter host cells. Once inside the cell, the toxin undergoes proteolytic cleavage, releasing lethal factor (LF) and edema factor (EF) into the cytoplasm. LF and EF then exert their toxic effects, leading to cell death and tissue damage.

In addition to its role in anthrax infection, Recombinant Mouse ANTXR2 Protein has been shown to play a role in other biological processes, such as cell adhesion, migration, and proliferation. It has also been implicated in the development of certain types of cancer, making it a potential target for cancer therapy.

Applications of Recombinant Mouse ANTXR2 Protein

Recombinant Mouse ANTXR2 Protein has a wide range of applications in the field of biotechnology and research. Its primary use is in the study of anthrax infection and the development of therapeutics against this deadly disease. Recombinant ANTXR2 Protein can be used to screen for novel inhibitors of anthrax toxin, as well as to study the mechanism of toxin entry into cells.

Moreover, Recombinant Mouse ANTXR2 Protein has been used in various cell-based assays to investigate its role in cell adhesion, migration, and proliferation. It has also been used to study the signaling pathways involved in ANTXR2-mediated cellular processes.

In the field of cancer research, Recombinant Mouse ANTXR2 Protein has been used to study its role in tumor growth and metastasis. It has also been investigated as a potential target for cancer therapy, with promising results in preclinical studies.

Furthermore, Recombinant Mouse ANTXR2 Protein has potential applications in the development of vaccines against anthrax. It has been used as an antigen in vaccine formulations, leading to the production of protective antibodies against anthrax toxin.

Conclusion

Recombinant Mouse ANTXR2 Protein is a critical protein involved in the pathogenesis of anthrax infection and has multiple biological functions. Its structure, activity, and applications make it a valuable tool in biotechnology and research. With ongoing studies and advancements in genetic engineering techniques, Recombinant Mouse ANTXR2 Protein will continue to play a significant role in the development of therapeutics and vaccines against anthrax and other diseases.